|
DPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43539999997166E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91359999857488E-08 |
| Normal-vs-Stage2 |
1.427220E-01 |
| Normal-vs-Stage3 |
4.617800E-03 |
| Normal-vs-Stage4 |
1.274030E-01 |
| Stage1-vs-Stage2 |
1.103820E-01 |
| Stage1-vs-Stage3 |
1.742810E-01 |
| Stage1-vs-Stage4 |
1.821520E-02 |
| Stage2-vs-Stage3 |
6.053400E-01 |
| Stage2-vs-Stage4 |
7.523800E-01 |
| Stage3-vs-Stage4 |
3.149200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63869999999911E-05 |
| Normal-vs-AfricanAmerican |
7.817400E-04 |
| Normal-vs-Asian |
7.797300E-03 |
| Caucasian-vs-AfricanAmerican |
7.444100E-02 |
| Caucasian-vs-Asian |
2.596700E-04 |
| AfricanAmerican-vs-Asian |
1.773800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.842400E-04 |
| Normal-vs-Female |
2.17349999998007E-07 |
| Male-vs-Female |
4.108400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.032400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.63789999954689E-07 |
| Normal-vs-Age(61-80Yrs) |
6.152200E-04 |
| Normal-vs-Age(81-100Yrs) |
4.833000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.074000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.913400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.558600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.160300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.035200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.561000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.119500E-03 |
| Normal-vs-Grade 2 |
1.34169999999045E-06 |
| Normal-vs-Grade 3 |
1.400270E-04 |
| Normal-vs-Grade 4 |
6.549400E-01 |
| Grade 1-vs-Grade 2 |
6.398800E-03 |
| Grade 1-vs-Grade 3 |
9.785100E-04 |
| Grade 1-vs-Grade 4 |
2.598600E-03 |
| Grade 2-vs-Grade 3 |
3.330200E-01 |
| Grade 2-vs-Grade 4 |
5.837700E-04 |
| Grade 3-vs-Grade 4 |
7.503600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.72369999998467E-07 |
| Normal-vs-ccB subtype |
4.408500E-02 |
| ccA subtype-vs-ccB subtype |
2.149600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.392100E-04 |
| Normal-vs-N1 |
1.363640E-01 |
| N0-vs-N1 |
8.230200E-01 |
|
|
